Aspects on Diagnosis and Treatment of the Foregut Carcinoid Syndrome
- 1 January 1992
- journal article
- Published by Taylor & Francis in Scandinavian Journal of Gastroenterology
- Vol. 27 (6) , 459-471
- https://doi.org/10.3109/00365529209000106
Abstract
Eight patients with the foregut carcinoid syndrome (two gastric and six bronchial primary tumors) are reported. The patients presented with complex clinical symptoms including ectopic production of adrenocorticotrophic hormone and growth hormone-releasing factors. The most alarming symptoms were facial flush and edema, accompanied by severe bronchoconstriction, which easily was misinterpreted as asthmatic attacks. Conventional bronchodilatory drugs may be potentially dangerous in these patients, in whom combined blockade of histamine receptors and treatment with cortisone and octreotide are recommended. Owing to the patients' age and general condition individualized long-term therapy was instituted. Surgical therapy under optimal protection by drugs can be of substantial value also in patients with advanced disease. One patient with life-threatening hormonal symptoms underwent hyperthermic perfusion of the liver with cytotoxic drugs, resulting in good palliation.Keywords
This publication has 57 references indexed in Scilit:
- Histamine containing endocrine cells in the human stomach.Gut, 1990
- Amine handling properties of human carcinoid tumour cells in tissue cultureNeurochemistry International, 1990
- What is the cause of the carcinoid flush?Gut, 1987
- Tachykinins in Carcinoid Tumors: Their Use as a Tumor Marker and Possible Role in the Carcinoid Flush*Journal of Clinical Endocrinology & Metabolism, 1986
- Histopathology of gastric carcinoids: a survey of 42 casesHistopathology, 1984
- The Carcinoid FlushNew England Journal of Medicine, 1978
- HISTAMINE METABOLISM IN CARCINOIDOSISThe Lancet, 1966
- THE CLASSIFICATION OF CARCINOID TUMOURSThe Lancet, 1963
- A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoidsThe American Journal of Medicine, 1962
- AN ATYPICAL CARCINOID TUMOUR SECRETING 5-HYDROXYTRYPTOPHANThe Lancet, 1958